Rischio di cancro nei pazienti IBD in terapia con AZA

Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case-Control Study. Armstrong RG, West J, Card TR. Am J Gastroenterol. 2010 Jan 26. [Epub ahead of print]  OBJECTIVES:Azathioprine is an accepted treatment of inflammatory bowel disease (IBD), but concerns exist regarding its carcinogenic potential. Studies in renal transplant and rheumatology patients have…

EUS in età pediatrica

EUS in pediatric patients.Attila T, Adler DG, Hilden K, Faigel DO. Gastrointest Endosc. 2009 Nov;70(5):892-8. Epub 2009 Jul 4.BACKGROUND: The knowledge of EUS use in children is limited. OBJECTIVE: We investigated the indications, feasibility, safety, and clinical utility of EUS in the management of pediatric GI, pancreatobiliary, and mediastinal diseases. DESIGN: Retrospective study.